Boehringer Ingelheim Corporation Release: New Long-Term Data Reinforce Safety Profile of Pradaxa® for Stroke Prevention in AF
6/17/2013
More...
|
Celgene International Sárl (CELG) Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients With Rare Form of Blood Disease
6/17/2013
More...
|
Novo Nordisk A/S (NVO) Release: Victoza® (Liraglutide [rDNA Origin] Injection) Safety Profile Further Supported at Scientific Workshop on Pancreatitis, Diabetes and Pancreatic Cancer
6/14/2013
More...
|
AbbVie (ABBV) Presents First Study Assessing the Role of Predefined Doses of Methotrexate When Used in Combination With HUMIRA™ (adalimumab) for Rheumatoid Arthritis
6/13/2013
More...
|
Bristol-Myers Squibb Company (BMY)'s Orencia Matches Abbott Laboratories (ABT)' Humira in Arthritis Study
6/12/2013
More...
|
Merck & Co., Inc. (MRK) Joins Novo Nordisk A/S (NVO) to Reassure Safety of Diabetes Drugs
6/12/2013
More...
|
Sanofi (France) (SAN.PA) Steps Up Diabetes Drive as Rivals Raise the Stakes
6/10/2013
More...
|
New Bird Flu Found to be Resistant to Roche (RHHBY)'s Tamiflu
5/30/2013
More...
|
Boehringer Ingelheim Corporation Release: New European Survey Highlights Ischaemic Stroke Protection as Treatment Priority for Patients With Atrial Fibrillation
5/28/2013
More...
|
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO): Study Shows Effects of Treatment With ABILIFY MAINTENA#0153; (Aripiprazole) on Psychiatric Hospitalization Rates for Patients With Schizophrenia1
5/21/2013
More...
|
"Love Hormone" Promises Safer Births After Pfizer Inc. (PFE) Flop
5/21/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Parkinson's Treatment Meets Study Goals
3/20/2013
More...
|
German Cost Regulator Rejects Bayer AG (BAY.F) and Regeneron Pharmaceuticals, Inc. (REGN) Eye Drug
3/20/2013
More...
|
EU Expands Use of Roche (RHHBY)'s Pegasys in Chronic Hepatitis C
3/18/2013
More...
|
Ferring Pharmaceuticals Data Suggest Lower Risk of Cardiovascular Events or Deaths in Prostate Cancer Patients Treated With Degarelix Compared to LHRH Agonists
3/18/2013
More...
|
Serious Side Effects Seen With Failed Merck & Co., Inc. (MRK) Niacin Drug
3/11/2013
More...
|
AbbVie (ABBV) Seeks to Block Release of Clinical Trial Data
3/11/2013
More...
|
Roche (RHHBY)'s Rituxan Cures Rare Skin-Blistering Disease in Study
3/8/2013
More...
|
National Institute for Clinical Excellence (NICE) U-Turn on Novartis AG (NVS)'s Xolair for Asthma
3/7/2013
More...
|
Boehringer Ingelheim Corporation Release: New Findings From Two Studies Support Substantial Benefit of Pradaxa® for Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism
2/21/2013
More...
|
Pfizer Inc. (PFE) Reports Positive Results in Studies of Toviaz, Pristiq, Chantix
1/24/2013
More...
|
Novartis AG (NVS) Says Afinitor Reduces Tumors in Rare Genetic Disease
1/11/2013
More...
|
Merck & Co., Inc. (MRK)'s Tredaptive is Under Review by European Medicines Agency After Failed Trial
12/26/2012
More...
|
Immune Response BioPharma Files for Orphan Designation of REMUNE for Pediatric HIV/AIDS
12/13/2012
More...
|
Novo Nordisk A/S (NVO) Bets on Turning Victoza Into Obesity Blockbuster
12/12/2012
More...
|
Celgene (CELG) Release: REVLIMID® and VIDAZA® Combination Therapy Achieves Nearly 30 Percent Complete Response in Untreated Elderly Patients With Acute Myeloid Leukemia
12/11/2012
More...
|
Celgene International Sárl (CELG) Release: Analysis of Post-Progression Outcomes in MM-015 Study Presented at the 54th American Society of Hematology Annual Meeting
12/11/2012
More...
|
Genentech (RHHBY)'s Perjeta Extends Life of Breast Cancer Patients by 34 Pct
12/11/2012
More...
|
Boehringer Ingelheim Corporation Release: Treatment With Pradaxa® Associated With Better Patient Outcomes After a Major Bleeding Event Compared to Warfarin
12/10/2012
More...
|
GlaxoSmithKline (GSK): We Conducted Paxil Clinical Trial Program Appropriately
12/7/2012
More...
|
AstraZeneca PLC (AZN) Release: Final Overall Survival Analysis of CONFIRM Shows a 4.1 Month Difference in Median Overall Survival When Using FASLODEX® (fulvestrant) Injection 500 mg Compared With 250 mg.1,2
12/5/2012
More...
|
Eli Lilly and Company (LLY)'s ED Drug, Cialis, Shows Promise in Rare Muscle Disease
11/30/2012
More...
|
Digoxin for Atrial Fibrillation Questioned After Deaths, Study Published in the European Heart Journal
11/28/2012
More...
|
Novo Nordisk A/S (NVO) Says New Data Show Victoza Advantage
11/27/2012
More...
|
Roche (RHHBY)'s Avastin Shows Mixed Results in Glioblastoma
11/23/2012
More...
|
Gilead Sciences, Inc. (GILD)'s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients
11/15/2012
More...
|
Gilead Sciences, Inc. (GILD)'s Once-Daily Single Tablet Regimen Stribild™ Maintains High Viral Suppression Through Two Years of Therapy Among Treatment-Naive HIV Patients
11/15/2012
More...
|
Boehringer Ingelheim Corporation Release: Recruitment Complete for Trajenta ® (linagliptin) Cardiovascular Outcome Study in Patients With Type 2 Diabetes
11/8/2012
More...
|
Boehringer Ingelheim Corporation Release: RELY-ABLE®: Unprecedented Long-Term Data Support Safety Profile and Sustained Efficacy of Pradaxa® for Stroke Prevention in AF
11/8/2012
More...
|
Boehringer Ingelheim Corporation Release: Safety and Efficacy of Pradaxa® (dabigatran etexilate) Reconfirmed in Clinical Setting for VTE Prevention After Total Knee or Hip Replacement
11/6/2012
More...
|
Novartis AG (NVS) Drug Works to Treat Rare Cushing's Disease
11/6/2012
More...
|
Boehringer Ingelheim GmbH Release: FDA and FDA Reaffirm Important Health Benefits and Safety of Pradaxa® (dabigatran etexilate) for Patients With Atrial Fibrillation
11/5/2012
More...
|
GlaxoSmithKline (GSK), Roche (RHHBY) Drugs Help Treat Breast Cancer in Brain
11/2/2012
More...
|
Wealth of Worldwide Evidence on Boehringer Ingelheim GmbH's Pradaxa® Including First Clinical Data on Long-Term Efficacy and Safety of a Novel Oral Anticoagulant to be Presented at American Heart Association Scientific Sessions
10/31/2012
More...
|
Novartis AG (NVS) Cannibalizes Gleevec to Boost New Cancer Drug
10/29/2012
More...
|
Sleep Tight: GlaxoSmithKline (GSK) Vaccine Not Linked To Narcolepsy
10/19/2012
More...
|
Eisai Company, Ltd. (ESALY.PK)'s Epilepsy Drug Helps Obese Patients Lose Weight
10/17/2012
More...
|
Sanofi (France) (SAN.PA)'s Genzyme Corporation (GENZ) Makes Progress With MS Drugs
10/15/2012
More...
|
Novartis AG (NVS)'s Gilenya Cuts Early Relapse, Brain Loss in MS Patients
10/12/2012
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: TYSABRI® (natalizumab) Data at ECTRIMS Reaffirm Positive Effects of Treatment for People With Relapsing Forms of MS
10/11/2012
More...
|
Sanofi (France) (SAN.PA) Says Zaltrap Cancer Drug Study Positive
10/9/2012
More...
|
Sanofi (France) (SAN.PA) Flags Positive Study on Lantus Insulin
10/5/2012
More...
|
Cancer Trials Show One Year on Roche (RHHBY)'s Herceptin is Best
10/1/2012
More...
|
Celgene (CELG)'s Abraxane is Talk of Cancer Meeting
10/1/2012
More...
|
New Janssen Pharmaceutica N.V. Data Demonstrate STELARA® (ustekinumab) is Effective, Well-Tolerated and Improved Quality of Life in Patients With Moderate to Severe Plaque Psoriasis
9/28/2012
More...
|
Boehringer Ingelheim GmbH Release: Asian Populations With Atrial Fibrillation (AF) Benefit From Better Stroke Prevention With Pradaxa® (dabigatran etexilate) Compared to Warfarin
9/12/2012
More...
|
New Data Confirms Safety of Novartis AG (NVS)'s Eye Drug Lucentis
9/5/2012
More...
|
Novartis AG (NVS) Smoker's Cough Treatment Beats GlaxoSmithKline (GSK)'s Advair in Trial
8/29/2012
More...
|
Bayer AG (BAY.F) Says Blood Thinner Cuts Risk of Repeat Heart Attack
8/29/2012
More...
|
The Medicines Company (MDCO) Release: Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
8/28/2012
More...
|
AstraZeneca PLC (AZN) Release: New European Society of Cardiology Guidelines Recommend BRILINTA (Ticagrelor) in Acute Coronary Syndromes Patients With ST-Elevation
8/28/2012
More...
|
Daiichi Sankyo, Inc. (4568.t), Eli Lilly and Company (LLY) Say Heart Drug Effient Fails to Meet Goal in a Phase III Trial
8/27/2012
More...
|
Boehringer Ingelheim Corporation Release: Cost Effectiveness and Clinical Efficacy of Pradaxa® (Dabigatran Etexilate) Versus Rivaroxaban Analysed
8/24/2012
More...
|
Bionor Pharma ASA Release: Study of Vacc-4x Combined With Celgene (CELG)'s Revlimid® (lenalidomide) in HIV Patients With Impaired Immune System Approved to Begin
8/13/2012
More...
|
Pfizer Inc. (PFE)'s Torisel Drug Fails in a Combination Study
8/13/2012
More...
|
Roche (RHHBY) Says Avastin Slows Brain Cancer Tumor Growth
8/10/2012
More...
|
Bristol-Myers Squibb Company (BMY) & AstraZeneca PLC (AZN) Release: Pooled Analysis Showed Onglyza® (saxagliptin) Provided Improvements in Key Measures of Blood Sugar Control in Adults With Type 2 Diabetes at High Risk for CV Disease
7/30/2012
More...
|
Roche (RHHBY)'s Lucentis Works to Treat Vision Loss from Diabetes
7/25/2012
More...
|
AstraZeneca PLC (AZN) Starts New Study of Heart Drug Versus Rival
7/18/2012
More...
|
GlaxoSmithKline (GSK), Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. (GILD) Atripla in Test
7/11/2012
More...
|
Merck KGaA (MKGAF.PK) Says Erbitux Fails in Stomach Cancer Trial
7/6/2012
More...
|
Orexo AB Takes Large Step Forward on the Road to Improve Treatment for People Dependent on Opioid Pain Killers
7/2/2012
More...
|
Shire plc Gaucher Drugs Beats Shire Pharmaceuticals (SHPGY) Med in Trial
6/28/2012
More...
|
Boehringer Ingelheim Corporation Release: No Significant Difference in the Risk of Acute Coronary Syndrome (including Myocardial Infarction) Seen With Pradaxa®(dabigatran etexilate) Compared to Enoxaparin for VTE Prevention After Orthopaedic Surgery
6/25/2012
More...
|
Genentech (RHHBY) Says Perjeta Combination Increased Survival in Breast Cancer Patients
6/22/2012
More...
|
FDA Staff Question Value of Sanofi (France) (SAN.PA) Blood Clot Drug
6/18/2012
More...
|
Sanofi (France) (SAN.PA) Announces Results of ORIGIN, the World's Longest and Largest Randomised Clinical Trial in Insulin in Pre- and Early Diabetes
6/15/2012
More...
|
GlaxoSmithKline (GSK)'s Avandia and University of Nottingham's Actos are Linked to Vision Problems
6/13/2012
More...
|
New Epidemiological Data Provide Additional Safety Evidence for Sanofi (France) (SAN.PA)'s Lantus(R)
6/12/2012
More...
|
Alkermes plc (ALKS) Release: INVEGA® SUSTENNA® Three-Month Formulation of Paliperidone Palmitate Enters Phase 3 Clinical Program for Schizophrenia
6/12/2012
More...
|
Sanofi (France) (SAN.PA)'s Lantus Shows No Cancer, Heart Risks: Study
6/12/2012
More...
|
Novo Nordisk A/S (NVO) Says Victoza Superior to Amylin Pharmaceuticals, Inc. (AMLN) Rival
6/12/2012
More...
|
Sanofi (France) (SAN.PA)'s Lantus Cut Blood Sugar More Than Merck & Co., Inc. (MRK)'s Januvia
6/11/2012
More...
|
Data From Follow-Up Study of Vertex Pharmaceuticals Incorporated (VRTX)' KALYDECO™ (ivacaftor) Showed Durable Improvements in Lung Function and Other Measures of Disease in People With Cystic Fibrosis Who Have a Specific Genetic Mutation (G551D)
6/8/2012
More...
|
Roche (RHHBY)'s Actemra Beats Abbott Laboratories (ABT) Drug in RA Trial
6/7/2012
More...
|
European Medicines Evaluation Agency Confirms Boehringer Ingelheim Corporation's Pradaxa Benefits, But Wants Clearer Guidance
5/25/2012
More...
|
Roche (RHHBY)'s Genentech (RHHBY) to Take Part in First-ever Alzheimer's Prevention Trial
5/21/2012
More...
|
Merck KGaA (MKGAF.PK)'s Erbitux Fails in Colon Cancer Study
5/9/2012
More...
|
Roche (RHHBY)'s Avastin and Novartis AG (NVS)'s Lucentis Equal for Treating Wet AMD - National Institutes of Health (NIH) Study
5/2/2012
More...
|
New Tysabri Data Presented at 64th Annual American Academy of Neurology Meeting Highlight Biogen Idec, Inc. (Massachusetts) (BIIB) & Biogen Idec, Inc. (Massachusetts) (BIIB) Commitment to Improving Outcomes in Multiple Sclerosis
4/27/2012
More...
|
Johnson & Johnson (JNJ) Alzheimer's Med Cut Chemical Tied to Brain Tangles
4/3/2012
More...
|
Servier's Protelos Effective Against Weak Bones
3/26/2012
More...
|
GlaxoSmithKline (GSK), Theravance, Inc. (THRX) Complete Registrational Program for Relovair; Reports Topline Results From Relovair(TM) vs. Advair(R) Phase III Studies in COPD
3/23/2012
More...
|
OncoGenex Pharmaceuticals Inc. Doubles Down on Prostate Cancer, as Competition Heats Up
3/12/2012
More...
|
Novartis AG (NVS) Cancer Drugs Fight Deadly Ebola Virus in Lab, Researchers Find
3/2/2012
More...
|
Roche (RHHBY)'s Zelboraf May Double Survival for Some Melanoma Patients
2/24/2012
More...
|
FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma
2/23/2012
More...
|
European Medicines Evaluation Agency Recommends Lifting Suspension of Bayer HealthCare (BAY)'s Trasylol
2/21/2012
More...
|
AB Science (AB.PA) Reports Positive Clinical Study Data: Masitinib Significantly Extends Overall Survival as Compared to Pfizer Inc. (PFE)'s Sutent®in Gleevec®-resistant GIST
2/1/2012
More...
|
Alkermes plc (ALKS) Initiates Open-Label Pilot Study of VIVITROL® to Evaluate Impact on Re-Arrest and Re-Incarceration in Offenders with History of Opioid Dependence
1/31/2012
More...
|
Allos Therapeutics, Inc. (ALTH) Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at theEuropean Medicines Evaluation Agency
1/30/2012
More...
|
Roche (RHHBY)'s Avastin Fights Early Breast Cancer in 2 Studies: Will it be Re-approved?
1/27/2012
More...
|
GlaxoSmithKline (GSK)'s Dutasteride May Slow Low-Risk Prostate Cancer: Debate Heats Up
1/24/2012
More...
|
Roche (RHHBY) Melanoma Drug Spurs Growth of Other Skin Cancers: Study
1/20/2012
More...
|
Sapheon, Inc. Announces One Year First-In-Man Data; Enrollment Commences in European Post Market Study
1/19/2012
More...
|
Roche (RHHBY)'s Avastin Disappoints Against Ovarian Cancer
1/3/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Release: Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE®
1/3/2012
More...
|
Study Challenges Bristol-Myers Squibb Company (BMY) on Bristol-Myers Squibb Company (BMY) and Sanofi (France) (SAN.PA)'s Plavix
12/29/2011
More...
|
EarlySense Release: Studies Show that EarlySense’s Contact-Free Patient Monitoring System Effectively Helps Hospital Patients Avoid Pressure Ulcers
12/19/2011
More...
|
Clinuvel Announces Positive Results From Pivotal European Phase III Study: Endpoints Demonstrate Clinically Relevant Treatment Effect of Afamelanotide
12/19/2011
More...
|
Human Genome Sciences, Inc. (HGSI) and GlaxoSmithKline (GSK) Initiate Phase 3 Trial of Belimumab (BENLYSTA®) Administered Subcutaneously in Subjects with Systemic Lupus Erythematosus
12/15/2011
More...
|
Celgene International Sárl (CELG) Release: Final Phase II Data Evaluating REVLIMID® and Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
12/14/2011
More...
|
Celgene International Sárl (CELG) Release: Premiere Cooperative Group in Adult Lymphoma Research (GELA) Chooses REVLIMID® for Study in Second Most Common Lymphoma Subtype
12/14/2011
More...
|
Celgene International Sárl (CELG) Release: Phase III Study Evaluating REVLIMID® in Patients with High-Risk Smoldering Multiple Myeloma Presented at American Society of Hematology
12/14/2011
More...
|
Two Novartis AG (NVS) Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
12/13/2011
More...
|
Celgene International Sárl (CELG) Release: Final Data from Phase II Multi-Center Study Evaluating Combination of VIDAZA® and REVLIMID® in Higher-Risk MDS Patients Presented at American Society of Hematology
12/13/2011
More...
|
Celgene International Sárl (CELG) Release: REVLIMID® Evaluated in Combination with Rituximab as a Potential Treatment for Patients with Treatment-Naive Chronic Lymphocytic Leukemia
12/13/2011
More...
|
Roche (RHHBY) Absorbs New Setback for Avastin as Cancer Treatment
12/12/2011
More...
|
Celgene International Sárl (CELG) Release: Dosing Study Evaluates REVLIMID® in Previously Treated Patients with Chronic Lymphocytic Leukemia
12/12/2011
More...
|
Celgene International Sárl (CELG) Release: Results from a Comparative Analysis Shows REVLIMID® Demonstrates Statistically Significant Reduction in Risk of Death and No Evidence of Increased Risk of Progression to AML in Patients with Deletion 5q MDS Compared with Best Supportive Care
12/12/2011
More...
|
Latest Data on Novartis AG (NVS) Afinitor Confirms Efficacy
12/9/2011
More...
|
GlaxoSmithKline (GSK) Drug Fails to Hit Goal in Breast Cancer Trial
12/9/2011
More...
|
Boehringer Ingelheim Corporation,Eli Lilly and Company (LLY) Release: Linagliptin Demonstrates Meaningful Improvement in Glycaemic Control in Initial Combination Therapy with Metformin
12/8/2011
More...
|
Pooled Analysis: Fewer Major Adverse Cardiovascular Events in People with Type 2 Diabetes Treated with Merck Sharp & Dohme (MRK)'s JANUVIA ® (sitagliptin)
12/6/2011
More...
|
Novo Nordisk A/S (NVO) Release: Data Show That the Combination of Insulin Degludec/Insulin Aspart Significantly Reduced Hypoglycaemia in Type 1 and Type 2 Diabetes Patients
12/6/2011
More...
|
Regeneron Pharmaceuticals, Inc. (REGN)-Bayer HealthCare (BAY) Drug Matches Lucentis at 2 Years in Fewer Doses
12/6/2011
More...
|
Midatech Group Receives Regulatory Approval for Clinically Testing Ultra-small Gold Nanoparticles
11/15/2011
More...
|
Sanofi (France) (SASY.PA)'s Multaq Doubled Deaths from Heart Disease in Study
11/15/2011
More...
|
The Medicines Company (MDCO) Release: German Researchers Reaffirm Utility of Angiomax(R)/Angiox(R) (Bivalirudin) in High Risk PCI Patients
11/14/2011
More...
|
Studies Show GlaxoSmithKline (GSK)'s HPV Vaccine Fights Cervical Cancer
11/9/2011
More...
|
Alkermes plc (ALKS) Release: New Long-Term Data on VIVITROL® Showed Sustained Efficacy and Safety over 18 Months of Treatment
11/9/2011
More...
|
Boehringer Ingelheim Corporation Release: Hepatitis C: Interferon-free Combination of BI 201335 Plus BI 207127 and ribavirin Shows up to 76% of Patients Achieve a Virological Response at Week 12, and 59% Achieve SVR12 with 16 Weeks Treatment 1
11/7/2011
More...
|
Ticagrelor Does Not Affect Pulmonary Function in ACS Patients, University of Sheffield Study
10/14/2011
More...
|
Novartis AG (NVS)' Onbrez Beats Boehringer Ingelheim Corporation/Pfizer Inc. (PFE)'s Spiriva for COPD Quality of Life
10/4/2011
More...
|
Merck & Co., Inc. (MRK), Sanofi (France) (SASY.PA) Cancer Vaccine Beats GlaxoSmithKline (GSK)'s Rival on Cost
9/29/2011
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Release: Analyses Find Type 2 Diabetes Patients Treated with BYDUREON(TM) Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011
9/12/2011
More...
|
National Institute for Clinical Excellence (NICE) Questions Merck & Co., Inc. (MRK), Nycomed COPD Drug
9/12/2011
More...
|
AstraZeneca PLC (AZN)'s Crestor Fails to Beat Pfizer Inc. (PFE)'s Lipitor
9/6/2011
More...
|
Head-to-Head Data on AstraZeneca PLC (AZN)'s Crestor Vs. Pfizer Inc. (PFE)'s Lipitor Results Due Soon
8/31/2011
More...
|
AstraZeneca PLC (AZN) Bloodthinner Shows Mortality Benefit Versus Sanofi (France) (SASY.PA)'s Plavix
8/30/2011
More...
|
GlaxoSmithKline (GSK) HPV Vaccine Protects Women From Anal Cancer
8/24/2011
More...
|
Roche (RHHBY)'s Herceptin Has Higher Heart Risk for Older Women
8/10/2011
More...
|
Roche (RHHBY) Cancer Drug Rejected by National Institute for Clinical Excellence (NICE) Found to Triple Survival Time
7/26/2011
More...
|
Bayer AG (BAY.F)'s Xarelto Blood Thinner Matched Warfarin in Japanese Safety Study
7/25/2011
More...
|
Sanofi (France) (SASY.PA) Halts Clinical Trial of Heart Drug Multaq
7/7/2011
More...
|
AstraZeneca PLC (AZN)'s Brilinta Worse With High-Dose Aspirin in Analysis
6/29/2011
More...
|
Old Osteoporosis Drug May Help In Killing Flu Viruses, University of Hong Kong Study
6/29/2011
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos, GlaxoSmithKline (GSK)'s Avandia Raise Risk of Eye Disease
6/27/2011
More...
|
One in Five Heart Attack Deaths Could be Prevented with New Drug, University of Sheffield Study
6/14/2011
More...
|
FDA Reviews Blood Clot Risk with Bayer Corporation (BAY) Contraceptives
6/1/2011
More...
|
Avastin Likely Will be Approved for Ovarian Cancer, Roche Holding AG (RHHBF.PK) Says
5/27/2011
More...
|
Bayer AG (BAY.F), Johnson & Johnson (JNJ)’s Xarelto Prevented Repeat Strokes in Analysis
5/25/2011
More...
|
Pfizer Inc. (PFE): Adding Inspra(R) (eplerenone) To Standard Therapy Reduces The Incidence Of New Onset Atrial Fibrillation/Flutter (AF/F) In Patients With Systolic Heart Failure, Sub-Analysis Shows
5/23/2011
More...
|
Viagra Could Reduce Multiple Sclerosis Symptoms, Autonoma de Barcelona Study
5/20/2011
More...
|
Crohn's Patients Respond to Johnson & Johnson (JNJ)'s Stelara in Study
5/9/2011
More...
|
Renal Cancer Drug Temsirolimus Shows Promise Against Mesothelioma, Medical University of Vienna Study
5/2/2011
More...
|
Extended-Release Naltrexone Can Be Used In Opioid Addicts; But Linked Comment Authors Criticise FDA For Ever Having Approved The Drug
4/28/2011
More...
|
Diabetes Treatment May Also Provide Protection Against Endometrial Cancer, University of Warwick and Warwick Medical School Study
4/6/2011
More...
|
Merck Serono: Erbitux Indication Extension Submitted for 1st-Line Advanced or Metastatic NSCLC in the EU
3/30/2011
More...
|
Boehringer Ingelheim Corporation: Dabigatran Etexilate is Cost-Effective for Stroke Prevention in Atrial Fibrillation
3/24/2011
More...
|
Novartis AG, Roche (RHHBY)’s Xolair Blunts Asthma Attacks in Children in U.S. Cities
3/17/2011
More...
|
Elan Corporation PLC (ELN), Biogen Idec, Inc. (Massachusetts) (BIIB) Tysabri Reports 10 More Brain Disease Cases
2/22/2011
More...
|
Novartis AG's Onbrez Plus Rival, Pfizer Inc. (PFE)'s Drug Boosts Lung Function
2/10/2011
More...
|
Genetic Immunity Presents the DermaPrep Transdermal Delivery System and DermaVir Nanomedicine-based Therapeutic Vaccine for HIV/AIDS at HIV DART 2010 Drug Development Conference
12/9/2010
More...
|
Pierre Fabre's Bladder Cancer Drug, Javlor too Costly for National Health Service, National Institute for Clinical Excellence (NICE) Says
11/23/2010
More...
|
Study on Acne Suicide Risk Fuels Debate Over Isotretinoin, Made By Mylan Inc. (MYL), Ranbaxy Pharmaceuticals Inc. and Teva Pharmaceutical Industries Limited (TEVA); Severe Acne Increases Suicide Risk, Even With Successful Treatment
11/12/2010
More...
|
Published Results Show Amgen (AMGN)'s Denosumab Superior to Novartis Corporation (NVS)'s Zometa(R) in Delaying or Preventing Bone Complications in Patients With Bone Metastases From Advanced Breast Cancer
11/9/2010
More...
|
Infectious Diseases Society of America: Linezolid Wins Battle on MRSA Pneumonia, Pitie-Salpetriere Hospital Study
10/27/2010
More...
|
Pfizer Inc. (PFE) Hormone, Prempro Almost Double Breast Cancer Death Risk in U.S. Research
10/20/2010
More...
|
Pfizer Inc. (PFE) Depression Drug Edronax Ineffective, May Be Harmful, Study in British Medical Journal Says
10/13/2010
More...
|
Eli Lilly and Company (LLY)'s Erbitux Fails In European Colon Cancer Study
10/11/2010
More...
|
Bayer HealthCare (BAY) and Onyx Pharmaceuticals, Inc. (ONXX) Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress
10/7/2010
More...
|
CSL Behring: Privigen(R) Demonstrates Efficacy and Tolerability Among Patients With Various Immunodeficiencies, Data Show
10/7/2010
More...
|
Boehringer Ingelheim Corporation, Pfizer Inc. (PFE)'s Spiriva Improves Asthma Treatment, Study Shows
9/22/2010
More...
|
Takeda Pharmaceuticals North America, Inc.'s Actos Has Same Heart Risks as GlaxoSmithKline (GSK)'s Avandia, Researchers Find
8/25/2010
More...
|
Teva Pharmaceutical Industries Limited (TEVA) and Lundbeck Inc. Release: TEMPO Extension Study Further Demonstrates the Benefits of Azilect(R) in Early Parkinson's Disease Patients
8/5/2010
More...
|
Glycotope Received Regulatory Approval for Glycooptimized and Fully Human Glycosylated Antibody CetuGEX(TM) and Enrolls First Patients in Clinical Trial
8/4/2010
More...
|
Clinuvel Release: Successful Drug Trial Results for Light Intolerant 'Shadow Jumpers'
7/13/2010
More...
|
Sanofi-Aventis (France) (SASY.PA) Less Glycemic Variability, Better Patient Reported Outcomes with Lantus(R) and Apidra(R) Regimen vs. Premix Analog Insulin
6/28/2010
More...
|
Gilead Sciences, Inc. (GILD) Head-to-Head Study of Cayston(R) Versus Tobramycin Inhalation Solution in Cystic Fibrosis Patients Achieves Co-Primary Efficacy Endpoint of Non-Inferiority
6/18/2010
More...
|
UCB, Inc. (UCBJF.PK): Neupro(R) (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease
6/17/2010
More...
|
Boehringer Ingelheim Corporation affirms safety of telmisartan with an analysis of 50,000 patients and strongly disagrees with the publication of Sipahi et al in Lancet Oncology June 2010
6/14/2010
More...
|
Boehringer Ingelheim Pharmaceuticals, Inc. Release: Dabigatran Etexilate as Effective and Safe as Enoxaparin in Preventing Venous Thromboembolism (VTE) After Total Hip Replacement Surgery and Significantly Reduced the Combined Endpoint of Major VTE and VTE-Related Death
6/11/2010
More...
|
Common Pain Relievers Raise Heart Risk for Healthy Folks, Gentofte University Hospital Study
6/9/2010
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Announces Positive Results from a Study Assessing a New Formulation of Copaxone(R)
6/4/2010
More...
|
UK's NICE Backs First-line Use of Johnson & Johnson (JNJ)'s Velcade
6/2/2010
More...
|
UK's NICE Rejects Novartis AG's Xolair for Children
6/1/2010
More...
|
Novo Nordisk A/S (NVO): Switching to Once-Daily Victoza(R) (Liraglutide [rDNA Origin] Injection) from Exenatide Further Improves Blood Sugar Control in Patients with Type 2 Diabetes
3/30/2010
More...
|
PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific Corporation (BSX)'s Novel Platinum Chromium TAXUS(R) Element(TM) Stent System
3/16/2010
More...
|
Common Cholesterol Drugs, Statins, Fight Cataracts, Too, Tel Aviv University Study
2/12/2010
More...
|
Moleac Announces Breakthrough Results on Neuroprotective and Neurogenerative Properties of NeuroAiD
2/11/2010
More...
|
Eli Lilly and Company (LLY): Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
2/3/2010
More...
|
Findings of Australian Trial of CSL Limited (CMXHF.PK)'s Pandemic (H1N1) 2009 ‘Swine’ Flu Vaccine in Children Published in Journal of the American Medical Association (JAMA)
12/21/2009
More...
|
Switching Immunosuppressants Reduces Cancer Risk In Kidney, Queen Elizabeth Hospital Study
11/2/2009
More...
|
Combination Antiretroviral Therapy Effective At Reducing HIV Resistance In Mothers And Babies Following Mother-to-child Transmission, Study Funded by Boehringer Ingelheim Corporation
10/28/2009
More...
|
Shire plc Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
10/28/2009
More...
|
Bowel Disease Drugs Increase Cancer Risk, Saint-Antoine Hospital Study
10/19/2009
More...
|
Rheumatoid Arthritis Biologics Increase Risk of Common Skin Cancer, University of Manchester Study
10/19/2009
More...
|
Older Antidepressant Spurs More Suicidal Thinking In Men Than Newer Medication, King's College London Study
10/16/2009
More...
|
Medications That Block Folic Acid In Pregnancy Double Risk Of Congenital Malformations In Fetus, Ben-Gurion University of the Negev Study
10/14/2009
More...
|